Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.

Sixteen patients with stable chronic asthma participated in a double blind crossover study comparing the new inhaled long acting beta 2 agonist formoterol with salbutamol. Inhaled (n = 15) and oral steroid (n = 1) treatment were maintained at the same daily dose throughout the study. For four weeks...

Descrición completa

Detalles Bibliográficos

Publicado en:	Thorax
Principais autores:	Wallin, A, Melander, B, Rosenhall, L, Sandström, T, Wåhlander, L
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMJ Publishing Group 1990
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC473768/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1972599/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.45.4.259
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!